Results 151 to 160 of about 50,123 (191)

The lights went out.

, 2012
Cavelaars, Chen, Cholesterol Treatment Trialists' Ctt Collaboration, Kromhout, Kunitz, Leon, S. Ebrahim, Uusitalo   +7 more
core   +1 more source

Cost-Effectiveness Analysis of Pneumococcal Vaccines in the Pediatric Population: A Systematic Review. [PDF]

Healthcare (Basel)
Vo NX, Pham HL, Bui UM, Ho HT, Bui TT.
europepmc   +1 more source

Cost-Effectiveness and Public Health Impact of 24-Valent Pneumococcal Conjugate Vaccine Compared With the Recommended Pneumococcal Vaccines in Older Adults. [PDF]

Am J Prev Med
Smith KJ, Wateska AR, Nowalk MP, Lin CJ, Harrison LH, Schaffner W, Zimmerman RK.   +6 more
europepmc   +1 more source

Designing ecologically optimized pneumococcal vaccines using population genomics. [PDF]

Nat Microbiol, 2020
Colijn C, Corander J, Croucher NJ.
europepmc   +1 more source

Correction: Omole et al. Safety, Tolerability, and Immunogenicity of the Pneumococcal Vaccines PPSV23 or PCV15 Co-Administered with a Booster Dose of mRNA-1273 SARS-CoV-2 Vaccine in Healthy Adults ≥50 Years of Age. <i>Vaccines</i> 2025, <i>13</i>, 192. [PDF]

Vaccines (Basel)
Omole T, Pelayo E, Weinberg AS, Chalkias S, Endale Z, Tamms G, Sterling TM, Good L, Shekar T, Johnson M, Banniettis N, Buchwald UK, Esteves-Jaramillo A.   +12 more
europepmc   +1 more source

Impact of influenza and pneumococcal vaccines on HIV persistence and immune dynamics during suppressive antiretroviral therapy. [PDF]

AIDS
Gianella S, Anderson C, Chaillon A, Wells A, Porrachia M, Caballero G, Meneses M, Lonergan J, Woodworth B, Gaitan NC, Rawlings SA, Muttera L, Harkness L, Little SJ, May S, Smith D.   +15 more
europepmc   +1 more source

Safety, Tolerability, and Immunogenicity of the Pneumococcal Vaccines PPSV23 or PCV15 Co-Administered with a Booster Dose of mRNA-1273 SARS-CoV-2 Vaccine in Healthy Adults ≥50 Years of Age. [PDF]

Vaccines (Basel)
Omole T, Pelayo E, Weinberg AS, Chalkias S, Endale Z, Tamms G, Sterling TM, Good L, Shekar T, Johnson M, Banniettis N, Buchwald UK, Esteves-Jaramillo A.   +12 more
europepmc   +1 more source

Limited protection of pneumococcal vaccines against emergent Streptococcus pneumoniae serotype 14/ST876 strains. [PDF]

Infection
Lan Y, Liu L, Hu D, Ge L, Xiang X, Peng M, Fu Y, Wang Y, Li S, Chen Y, Jiang Y, Tu Y, Vidal JE, Yu Y, Chen Z, Wu X.   +15 more
europepmc   +1 more source

Comparing serotype coverage of pneumococcal vaccines with PCV21 (V116), a new 21-valent conjugate pneumococcal vaccine, and the epidemiology of its eight unique Streptococcus pneumoniae serotypes (15A, 15C, 16F, 23A, 23B, 24F, 31 and 35B) causing invasive pneumococcal disease in adult patients in Canada: SAVE study, 2018-21. [PDF]

J Antimicrob Chemother
Schellenberg JJ, Adam HJ, Baxter MR, Karlowsky JA, Golden AR, Martin I, Zhanel GG.   +6 more
europepmc   +1 more source